Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of SAMRAT PHARMA. For more details, see the SAMRAT PHARMA quarterly results and SAMRAT PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.9 |
No. of shares | m | 3.09 |
1 Week | % | -3.4 |
1 Month | % | 12.9 |
1 Year | % | -33.4 |
52 week H/L | Rs | 604.3/320.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SAMRAT PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 164 | 132 | 159 | 578 | 1,250 | |
Low | Rs | 49 | 47 | 58 | 135 | 332 | |
Sales per share (Unadj.) | Rs | 313.6 | 381.2 | 497.3 | 717.6 | 1,005.3 | |
Earnings per share (Unadj.) | Rs | 5.0 | 13.7 | 17.3 | 55.6 | 53.8 | |
Diluted earnings per share | Rs | 5.0 | 13.7 | 17.3 | 55.6 | 53.8 | |
Cash flow per share (Unadj.) | Rs | 6.3 | 15.1 | 18.9 | 57.5 | 55.9 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 1.00 | 1.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0.3 | 0.1 | |
Book value per share (Unadj.) | Rs | 64.9 | 78.7 | 95.9 | 151.5 | 204.3 | |
Adj. book value per share | Rs | 64.9 | 78.7 | 95.9 | 151.5 | 204.4 | |
Shares outstanding (eoy) | m | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
Price / Sales ratio | x | 0.3 | 0.2 | 0.2 | 0.5 | 0.8 | |
Avg P/E ratio | x | 21.4 | 6.5 | 6.3 | 6.4 | 14.7 | |
P/CF ratio (eoy) | x | 16.8 | 5.9 | 5.8 | 6.2 | 14.1 | |
Price / Book Value ratio | x | 1.6 | 1.1 | 1.1 | 2.4 | 3.9 | |
Dividend payout | % | 0 | 0 | 0 | 1.8 | 1.9 | |
Avg Mkt Cap | Rs m | 328 | 277 | 335 | 1,101 | 2,444 | |
Total wages/salary | Rs m | 9 | 10 | 11 | 10 | 11 |
SAMRAT PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 969 | 1,178 | 1,537 | 2,218 | 3,106 | |
Other income | Rs m | 5 | 6 | 5 | 6 | 5 | |
Total revenues | Rs m | 974 | 1,184 | 1,541 | 2,224 | 3,111 | |
Gross profit | Rs m | 32 | 66 | 87 | 242 | 239 | |
Depreciation | Rs m | 4 | 4 | 5 | 6 | 6 | |
Interest | Rs m | 11 | 10 | 13 | 7 | 12 | |
Profit before tax | Rs m | 22 | 58 | 73 | 236 | 225 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 6 | 15 | 20 | 64 | 59 | |
Profit after tax | Rs m | 15 | 42 | 53 | 172 | 166 | |
Gross profit margin | % | 3.3 | 5.6 | 5.6 | 10.9 | 7.7 | |
Effective tax rate | % | 28.8 | 26.8 | 27.4 | 27.2 | 26.2 | |
Net profit margin | % | 1.6 | 3.6 | 3.5 | 7.7 | 5.4 |
SAMRAT PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 328 | 497 | 473 | 713 | 986 | |
Current liabilities | Rs m | 193 | 339 | 273 | 373 | 528 | |
Net working cap to sales | % | 13.9 | 13.4 | 13.0 | 15.3 | 14.8 | |
Current ratio | x | 1.7 | 1.5 | 1.7 | 1.9 | 1.9 | |
Inventory Days | Days | 2 | 1 | 2 | 6 | 8 | |
Debtors Days | Days | 79,271,910 | 86,186,005 | 784 | 717 | 602 | |
Net fixed assets | Rs m | 75 | 87 | 101 | 134 | 175 | |
Share capital | Rs m | 31 | 31 | 31 | 31 | 31 | |
"Free" reserves | Rs m | 170 | 212 | 265 | 437 | 601 | |
Net worth | Rs m | 201 | 243 | 296 | 468 | 631 | |
Long term debt | Rs m | 3 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 402 | 583 | 574 | 846 | 1,162 | |
Interest coverage | x | 3.0 | 6.9 | 6.8 | 36.0 | 19.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.4 | 2.0 | 2.7 | 2.6 | 2.7 | |
Return on assets | % | 6.4 | 8.9 | 11.5 | 21.1 | 15.4 | |
Return on equity | % | 7.7 | 17.4 | 18.0 | 36.7 | 26.3 | |
Return on capital | % | 15.8 | 27.8 | 29.1 | 51.8 | 37.6 | |
Exports to sales | % | 19.0 | 5.9 | 8.9 | 4.8 | 4.1 | |
Imports to sales | % | 87.1 | 94.7 | 86.8 | 68.9 | 83.3 | |
Exports (fob) | Rs m | 184 | 69 | 137 | 107 | 127 | |
Imports (cif) | Rs m | 844 | 1,115 | 1,334 | 1,528 | 2,587 | |
Fx inflow | Rs m | 184 | 69 | 137 | 107 | 127 | |
Fx outflow | Rs m | 844 | 1,116 | 1,334 | 1,528 | 2,587 | |
Net fx | Rs m | -660 | -1,046 | -1,198 | -1,421 | -2,460 |
SAMRAT PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 24 | -13 | 48 | 175 | -94 | |
From Investments | Rs m | 22 | -19 | -29 | -11 | -30 | |
From Financial Activity | Rs m | -39 | 20 | -19 | -19 | 96 | |
Net Cashflow | Rs m | 6 | -12 | -0 | 145 | -28 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Lalit Mehta | COMP SEC: Nishant Kankaria | YEAR OF INC: 1992 | BSE CODE: 530125 | FV (Rs): 10 | DIV YIELD (%): 0.3 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SAMRAT PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets yesterday.